Although much interesting work has been done by economists such as Francis, Kremer and Philipson on infectious diseases, this literature does not set out the general structure of the externalities involved in such situations. This paper provides a general framework for discussing these externalities and the role for government interventions to offset them. It moves the discussion away from its focus on HIV, a fatal infection for which there are few interventions, and its focus on vaccinations, that are plausibly discrete decisions, to more general ideas of prevention and cure that are applicable to many more diseases in which interventions exhibit a continuum of intensities subject to diminishing marginal returns.
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Introduction
The economic approach to infectious diseases is in its infancy, somewhat oddly because many economists have long had the intuition that epidemics and infectious diseases are quintessential manifestations of the principle of an externality, itself a central concept in economics (Brito et al. 1991) . Furthermore, epidemiology provides ready-made dynamic models of disease transmission and economics provides methods of dynamic optimization, and ones that provide guidelines for policy. Policy toward infections is of great importance. Yet only recently have economists begun to look at these questions in a formal way. This paper has two main goals. The overarching goal is to dissect the externalities involved in infectious diseases when there are the options of both prevention and cures, so that the relative phasing of these two types of interventions is important. Furthermore, we want to see how externalities are manifested with regard to these two types of interventions. To achieve this goal, we need to state the social planner's or first-best problem and to compare it to a representative agent's problem. To avoid compounding the identification of any externalities with problems of myopia, imperfect ability to insure health outcomes, or a disregard for the welfare of future generations, we choose a formulation of the representative agent in which these problems do not arise, allowing us to focus exclusively on the externalities that we identify.
The economic literature on infectious diseases has taken as its starting point some special although important concerns. This starting point has influenced modeling strategies in ways that we believe obscures the general structure of private choice and consequent externalities in the process of disease transmission. One focus of the previous literature has been on vaccinations (Brito et al. 1991 , Francis 1997 , Geoffard and Philipson 1997 and Kremer 1996 . It is certainly an important intervention but one that is only possible for a limited number of diseases.
1 Wickwire (1977) surveys early work and Sethi and Staats (1978) , Greenhalgh (1988) and Hocking (1991) are more recent. This literature, however, has several shortcomings. First, the objective function is often poorly specified, with no discounting and a finite horizon. More importantly, marginal costs and benefits are typically assumed constant leading to unrealistic bang-bang solutions. Usually, there is no discussion of the co-ordination of multiple interventions. Finally, these models do not incorporate health choices by individuals, and therefore do not discuss externalities and the decentralization of the optimal policies, a topic we stress.
3 one type of intervention in isolation. He models the use of two interventions in the case of bilharzia, but under assumptions about costs and benefits that imply that one of the two interventions is used maximally or not at all. Furthermore, he does not model decisions by individuals and the associated externalities of this type of vector-spread disease. Epidemiologists have also analyzed the problem of optimal interventions to control infections, but have not surprisingly ignored many of the issues we investigate. 1 Once we have adopted a framework that can achieve our first goal, our second goal is to examine a typology of infectious diseases. This typology allows for people to progress from being susceptible to infected (and infectious) to: (1) recovered but again susceptible, or (2) immune, or (3) dead. Furthermore, the typology includes diseases that spread from person to person and those that are spread by intermediate vectors, such as mosquitos. Finally, the typology allows for the targeting of different interventions at different groups. We show how these different characteristics of the epidemic affect conclusions about how to offset externalites and how the preventive and curative interventions are phased relative to each other.
In fact, we identify two types of externalities: First, infectious people can infect other people who in turn infect others and so on, the source of what we call the pure infection externality. This externality arises if, in choosing their own levels of preventive and curative effort, people do not fully take into account the costs to others who will become infected as a 4 consequence of their being infectious. Second, there is a pure prevention externality that arises because the preventive actions of one individual may directly affect the probability that other people become infected, whether or not the preventive action prevents infection of the individual undertaking it. Typically, the pure prevention externality arises only for diseases that involve a vector and therefore appears only in the last model of the paper. An example is the use of insecticides to kill mosquitos that carry disease. The person using the insecticide may or may not be bitten and infected but the killing of mosquitos lessens the probability that others will be bitten and infected, something that the user of the insecticide may disregard.
As is conventional in modeling externalities, the paper begins with the problem of a hypothetical social planner who can directly control all preventive and curative actions, initially in a model of infection from person to person. First, we lay out the accounting for the people who are in different disease statuses and the dynamics that move people from one status to another, the constraints on the optimization problem. Next, we introduce the objective of decision takers: the maximization of utility net of the costs of the disease in terms of discomfort, fear and economic loss and net of the costs of preventive and curative measures. We then maximize the objective function subject to the constraints, and look at the optimal solution to the social planner's problem and how it depends on what happens to people who are infected. The next section looks at the decentralized decisions, their deviation from the social planner's choices, and hence the existence of externalities and the role for public interventions. A penultimate section looks at some of these issues when vectors transmit disease. The paper ends with some concluding remarks.
2
We assume that each person has the same rate of contacts. Kremer (1996) examines some behavioral aspects of models in which different people have different rates of contact. 
The Social Planner's Problem
A. The Dynamic Constraints
The starting point for the study of optimal policy toward infectious diseases is the classic literature on mathematical epidemiology. It provides the dynamic constraints that condition decisions about infectious diseases. This literature models many diseases, ones transmitted directly from person to person and ones transmitted by vectors (Anderson and May, 1991) .
In the most general model of diseases transmitted from person to person that we consider, the total number of people (N) is the sum of the number who are: (1) susceptible (S); (2) infected and infectious (I); and (3) recovered and immune, i.e. uninfectible (U):
The proportions of these groups in the population are denoted by s, i, and u, with s + i + u = 1 .
The birth rate of the population is ε while deaths only occur as a proportion, δ, of the infections at any time, so that the net change in the population is:
The number of susceptibles changes according to:
The first part of the right-hand side embodies the assumption that all newborns are susceptible.
The second part reduces the number of susceptibles by those people who become infected.
Under the assumption of random contacts, the probability per contact of a susceptible person's meeting an infected (and infectious) person is the proportion of infected people in the population, i=I/N.
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The product, Si, is the number of susceptibles who do so. The factor α is an adjustment 6 incorporating both the rate of contact and the inherent infectiousness of an infected (or susceptibility of a susceptible). The third part is the addition to the susceptible pool resulting from the recovery of a fraction, β, of the infecteds.
The number of infecteds evolves according to:
The first three terms on the right-hand side have been discussed in connection with equations (2) and (3). The last term accounts for the transition of the fraction γ of the infecteds to the status of immunes. Correspondingly, the number of immunes evolves according to:
These equations can be solved for the change in the three proportions:
In the subsequent discussion, we will consider how preventive and curative actions by governments and individuals affect the parameters of the model: α, β, δ, and γ. Without any such interventions, however, these parameters are fixed, and the model of equations (5)- (8) evolves to a steady state. In particular, the steady state may be one in which s = 1 and i=u=0 and the disease disappears, rather than one in which s, i and u lie strictly between 0 and 1. In the former case, optimal policy would be to approach optimally the steady state in which the disease disappears.
In other cases, it may be desirable to adopt policies that eradicate the disease even though in the absence of interventions the steady-state proportion of infecteds would be positive. With few exceptions, however, we do not believe that eradication, optimal or otherwise, is feasible, and we
will be studying situations in which optimal policy involves optimally moving to and sustaining a steady state with a positive level of infection.
B. The Objectives and the Optimization
We are now ready to specify the social planner's objective function and then to provide necessary conditions for a maximization of this objective function with respect to expenditures on preventive and curative actions. The government controls two policy variables, preventive effort of a A 0 units and curative effort of b A 0 units. These health inputs affect the parameters of the model, α(a) and β(b), γ(b) and δ(b) and thereby determine respectively the rate of infection and the rates of transition to recovered-but-susceptible, immune, and dead. The controls exhibit diminishing marginal products so that: α'<0, α">0, β'>0, β"<0, γ'>0, γ"<0, and δ'<0, δ">0. This property of our formulation distinguishes it from all the preceding work that we know, and it opens the scope for internal solutions to the optimal policy problem and for the analysis of the co-ordination of multiple interventions phased in a smooth way over the course of an epidemic.
We believe that for many if not all diseases there is scope for undertaking additional preventive and curative interventions that are marginally less and less productive. Interventions are costly;
preventive effort costs p a per unit and curative effort costs p b per unit.
The objective of government policy is to maximize the present discounted value of social welfare:
in which r is the discount rate, V 0 is the money value of utility in the absence of the disease, p I is 8 the current money cost of being infected (and sick) such as foregone wages while ill and including the monetary equivalent of pain and suffering, p a is the cost per unit of the preventive intervention of amount a, and p b is the cost per unit of the curative intervention of amount b. The integrand of equation (9) 
a choice variable, but in this paper we will assume that it is a technical given and compare the behavior of the model under different targeting assumptions.
Equation (9) therefore provides the objective function while equations (2) and (6)- (8) provide the dynamic equations that constrain the optimization problem. The current-value
Hamiltonian, H, is:
in which (λ s N), λ N and (λ i N) are the current value multipliers.
The first derivatives of H with respect to the controls, a and b, set equal to zero imply:
and Under the assumptions on the θ j and on α' and β', the difference between λ s and λ i must be positive if the first-order conditions are to hold. In addition, the dynamic equations for the multipliers imply:
Inspection of equations (6), (7) and (11a-e) shows that the dynamic equations for s, i, and the λ j , j = s,i, N do not involve N so that the dynamic system is independent of N although not of ε or λ N .
To develop the analysis further we turn to some special cases.
C. The Special Case of Susceptible-Infected-Susceptible (SIS)
The model of a disease in which people recover only to become susceptible rather than immune or die is the simplest case of the preceding model of any relevance. Many of the classic sexually transmitted diseases fall in this category. In this case, γ = δ = U=u = 0; the controls remain the variables a and b while the states are s and i. With the substitution of i = (1-s) in the current-value Hamiltonian, equation (10), λ i can be dropped as can be λ N because the model is expressible without reference to the total size of the population, N, once no one dies. The growth rate of population is still a parameter because it determines part of the growth of the susceptibles.
The model therefore only has one state variable, s, with dynamic equation:
Equations (11a-b) simplify in this case to:
and Equation (13a) equates the marginal cost of an increase in the preventive intervention as determined by the product of its price and targeting function to the marginal benefit of the
increase in the proportion of the population that is uninfected achieved by the increase in prevention. Equation (13b) similarly equates the marginal cost of an increase in curative intervention as determined by the product of its price and targeting function to the marginal benefit of the increase in the proportion of the population that is uninfected achieved by the increase in curative effort. All marginal costs and benefits are expressed in terms of the welfare of the average member of the economy measured in dollars.
The variable λ s equals the shadow benefit in dollars to the average member of the economy of an increase in the proportion of the population that is uninfected. Under the assumptions on the θ j and on α' and β', the λ s must be positive if the first-order conditions are to hold. In addition, the dynamic equation for the multiplier implies:
As before, the θ j , j = a, b in equation (12)- (13c) regardless of the value of s, two cases that are less easy to interpret intuitively. The ratios of the marginal products do not translate directly into the ratios of the inputs themselves, perhaps the most direct measure of the relative size of the two efforts. But, there are special cases when the
two ratios do move together (see Appendix A for an example) and so Φ helps to understand the possibilities for the co-movements of the physical inputs during the evolution of an epidemic.
To simplify what follows, we assume that θ So far we have proceeded on the presumption that the first-order conditions determine a maximum. In fact, the most generally-used sufficiency conditions for a maximum do not obtain in this model, but we believe that the way we have characterized the maximization is, in fact, correct for a very large class of these models . While the problem is concave in the controls because they are subject to diminishing marginal returns, it is not concave in the state because the dynamic equation exhibits increasing marginal returns in the state, a fundamental property of contagion as posited by epidemiologists. Correspondingly, the failure of the sufficiency conditions is not a reflection of the linearity of the instantaneous utility function [the integrand of equation (9)]. Appendix A discusses these issues in detail.
Setting equations (12) In these cases the term (α+α'sa s ) may be positive or negative and therefore the numerator of equation (16a) and the denominator of equation (16b) may be positive or negative. Note, however, that if the denominator of (16b) is negative, so must be the numerator of equation (16a); it is not possible to have a positively sloped s . =0 locus and a negatively sloped λ .
s =0 locus.
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The results in this sentence follow from the application of such standard references as Kamien and Schwartz (1981, Appendix B) . The saddlepoint case is their Case IC. in r leads to a diminished weight of the future in decisions, an increase in r leads to an increase in the optimal steady-state proportion of the population that is infected.
The effects of the other two parameters are more complicated, however, because both loci shift. The impact effect (s and λ s fixed) of an increase in the price of either preventive or curative interventions is to decrease the amount used via equations (15c) and (15f) and therefore either a and α or b and β are affected in both equations.
In the case of an increase in p b , the s . = 0 locus always shifts up regardless of the sign of its slope. The λ .
s =0 locus shifts up if its slope is positive and down if its slope is negative. In the case of an equilibrium of the type illustrated in Figure 1a , therefore, the shift in the s . =0 locus tends to lower s * while the shift in the λ .
s =0 locus tends to raise s * and the net outcome is ambiguous even when the algebraic magnitudes of these shifts are taken into account. The rationale for this ambiguity is as follows: The price of a curative intervention, p b , enters the dynamic equation for the co-state variable in the same way as the cost of being infected, p I . One of the effects of an increase in p b is therefore to raise s, just as an increase in p I does; in effect an increase in the cost of being cured is like an increase in the cost of being infected because every infection induces expenditures on curative inputs. But there is also the fact that it is more expensive to be cured so that it may be desirable to spend less on b and be cured less quickly.
That the first effect can dominate is easily seen from the special case when b is fixed at some positive value (perhaps for technological reasons) so that the curative effort is not adjusted in response to its price increase. The preventive intervention can still respond, however, as it would to a change in p I and the steady state proportion of the uninfected, s * , is thereby increased. Recall that cases IIB and D of Table 1 must conform to this latter pattern of an ambiguous impact of p b .
In contrast, starting from an equilibrium of the type illustrated in Figure 1c, 
D. The Special Case of Susceptible-Infected-Dead (SID)
If all people who become infected die, the general model of equation (10) The specialized versions of equations (6) and (11a-d) are independent of N but not of λ N and therefore so are the solutions for the optimal interventions, a and b, and for the state of the epidemic, s. The first result implies that the interventions are independent of the scale of the
economy. The second result implies that the dimension of the system is three (s, λ s and λ N ) rather than the two of the SIS model. This important difference between the two models arises because the infected die in the SID model which is valued by λ N , rather than returning to the susceptible state which is valued at λ s , as in the SIS model. Consequently, the SID model is significantly less tractable than the SIS model. The solutions for the SID case are not independent of ε which appears in the specialized versions of equations (6) and (11c and The SID first-order conditions imply that:
In contrast to the SIS model, there is therefore no closed-form solution corresponding to the relationship between s and Φ in the SIS case, so there is the potential for very much more complicated relationships than those reported in Table 1 .
E. The Special Case of Susceptible-Infected-Uninfectible (SIU)
This case corresponds to β = δ = 0; individuals who are susceptible become infected and then immune. The states are s, i and u=(1-s-i) and the contols are a and b. The only substantive simplification of the social planner's problem that we have been able to identify in this case is that the five-dimensional system of section 1B can be reduced to four because λ N does not appear in the dynamic equations for the other variables because people do not die of the disease. We therefore do not present any results for this case except in section 2D on decentralization.
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Decentralization
A. The General Problem of Decentralization
To this point we have discussed the problem of the social planner who directly controls the values of a and b in a model without people who make decisions that affect their own health.
The next step is to consider private decisions and their implications for government policy. If people do not take into account the effect on the infection of the general population caused by their ability to infect others if they become infected, they generate a pure infection externality. In our formulation of diseases in which one person directly infects another, the preventive activity of one individual does not, however, affect the probability that other people become infected independently of whether the first person becomes infected, so there is no preventive externality.
Once we identify the externality, we examine how government interventions with subsidies or taxes can decentralize the social planner's first-best solution.
In our abstract formulation, governments can subsidize preventive and curative activities, the privately chosen values of a and b. In reality, for some diseases, there will be some inputs that are marketed and some inputs that involve individuals' non-marketed and unobservable actions such as avoiding crowded places to varying degrees in the case of tuberculosis prevention or adhering meticulously to drug regimens. When a and b involve such non-marketed and unobservable actions the subsidy/tax interventions we propose may be infeasible or may have to be targeted only on the marketed components of preventive and curative activities with secondbest implications.
The simplest way to illustrate the pure infection externality and its implications for policy is to assume that private decisions are made by a group of people that we call a family, a construct that we use as the representative decision-making agent. This construct provides a logically consistent and analytically tractable model to contrast with the model of the social planner: First, the family's objective function is fully congruent with the social planner's.
Furthermore, the family understands and anticipates how the epidemic will evolve and is fully forward-looking with regard to their possible future statuses as well as their present situation.
Unlike Kremer's (1996) modeling of individuals' behavior which is only oriented to the conditions in the current period, our family takes account in its current decisions of the evolution of the epidemic, its implications for the future risk of infection, and its implications for all the family's descendants. For instance, if the future probability of infection is high it affects the current incentive of the family to make curative expenditures. It is therefore the case that our rationale for government interventions do not depend either on myopia or on a discrepancy between the social planner's and the representative agents' valuation of outcomes over the path of the epidemic.
As is conventional in the public-economics treatment of externalities, the only distinction between the social planner and the representative agent is that the family is assumed to be small relative to the population as a whole, in this case so that the proportion of the family in any disease status does not affect the proportion of the population as a whole that is in that status. In particular, this family takes as given the proportion of the population that is infected, which equals the probability, π, that any random contact is with an infected person. Second, the family is assumed to be sufficiently large that it can fulfill the role of a representative agent and therefore that the proportion of the family in each disease status is identical to the population proportions. Finally, it is this family that takes decisions about the interventions, a and b.
Because the instantaneous utility function is linear, there is no sense in which the family is performing any implicit insurance function for its members. A perhaps more realistic but only 22 perhaps (because people do indeed live in families) and less tractable approach would build the private economy up from representative individuals each of whom is in one or another diseases statuses at any one time and taking decisions about either prevention or cure (or neither if already immune), with regard to their possible future statuses as well as their present situation. For diseases in which people transit from susceptible to infected to dead, the individual's problem seems tractable, because death is obviously an absorbing state. But for individuals who cycle between susceptible and infected, we have not been able to manage a formulation and we leave this task for the future, but see no reason why such a formulation should fundamentally alter the nature of the externalities that we identify.
The dynamic equations of this version of the model are the same as in section 1A, except that in equations (3) and (4) the term αSi is replaced by αSπ to denote the exogeneity from the family's viewpoint of the proportion, π, of the population (in contrast to the proportion, i, of the family) that is infected. There is a consequent change in equations (6) and (7).
A further change has to be made to the objective function to reflect the possibility of government interventions. If there is an externality, the government may find it optimal to subsidize or tax preventive and/or curative inputs. To allow for these possibilities, we assume that the representative family faces prices of q j = (1+t j )p j , j = a, b. As is standard in public economics, so that any interventions are revenue neutral in a way that does not have any incentive effects beyond the t j , we assume that the family receives a lump sum payment (possibly negative) of T that it takes as exogenous to its own actions but that in fact equals t a p a a 
D. Decentralization in the SIU Model
Decentralization is harder to analyze in the SIU model than in either the SIS or the SID models. In the SIS and SID models there is only one multiplier equation that differs between the social planner's and the family's problems, that associated with the change in s, whereas in the SIU model there are two, associated with the changes in s and in i. We have therefore only been able to characterize the government's optimal interventions at the steady state.
Comparison of the results from the first-order conditions of the two problems shows that:
These two equations plus the property that in the steady state (1+t a ) λ . 
Control of a Vector-Borne SIS Disease
Many infectious diseases are transmitted through intermediate hosts, such as mosquitos, flies, ticks and snails. These hosts must be infected to play their part in the cycle of infection.
For instance, in the case of malaria, infected mosquitos inject people with one stage of the parasite thereby infecting them. Uninfected mosquitos that bite infected people are in turn infected by a later developmental stage of the parasite in an infected person's blood, thereby continuing the cycle. Interventions to affect the prevalence of these diseases can take many forms and the package is more complicated than the distinction between preventive and curative in sections 1 and 2. The dynamic structure of infection in our model, equations (24) and (25), is an adaptation of the discussion in Anderson and May (1991) . As does their basic model, we ignore deaths from malaria and the existence of an animal reservoir of infection on which mosquitos feed in addition to the human population.
(24)
A model of malaria transmission must, therefore, comprise equations for the number of people who are infected (I) and the number of mosquitos that are infected (Y). For simplicity, we will assume that the total population (of people) is fixed at N, so that there is neither natural growth in the population nor are there deaths associated with malaria. The sum of the number of susceptibles (S) and infecteds equals the whole population, S+I = N, and s, as before, is the proportion of the population that is susceptible. Because we are interested in interventions that affect the total number of mosquitos (M), we also specify the dynamics of the total mosquito population.
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The number of infected people evolves according to:
The first part of this equation is the product of the number of people who are susceptible (N-I), the proportion of mosquitos that are infected (y=Y/M), the ratio of mosquitos to people (m=M/N) and two parameters α 1 , the number of bites that the average mosquito manages per unit time, and α 2 , the proportion of bites by infected mosquitos that lead to a human infection. The second part of the equation is the rate of recovery of infecteds.
The number of infected mosquitos evolves according to:
The first part of this equation is the product of the number of mosquitos (M-Y) that are the equal-rate result of the SIS model and has the same intuition. So long as λ y < 0, comparison of equation (29a) with equation (32a) shows that a 1 is subsidized less (or taxed more) than a 2 and b.
Conclusions
Our starting point for this paper has been a commonsensical one: Mathematical epidemiology provides a parsimonious representation of how infectious diseases spread.
Economics suggests an objective function to evaluate the costs of infection and its associated offsetting interventions, and especially a role for diminishing returns in the interventions that affect the evolution of the epidemic. All these elements taken together specify the objectives and constraints that determine optimal interventions for public health in a hypothetical centrally planned economy. The discrepancy between the social planner's solution and decentralized decision making defines externalities in the economy, and the scope for subsidy/tax interventions by government to maximize private welfare in the absence of central control of all decisions.
Although we set out a general formulation of this problem for infections that proceed either to recovery and further susceptibility, immunity or death as well as a variant of an infection that depends on vectors, by far the most tractable case is the first, the SIS model. For this type of disease, we looked at the effects of different targeting schemes on the phasing of preventive inputs relative to curative ones, the response of the steady-state level of susceptibility to the different prices in the model, and the role of subsidies in decentralizing the social planner's problem. In this model, the optimal intervention is a subsidy at the same rate to both preventive and curative activities, both in the steady state and during the approach to it, and the result does not depend on the form of targeting. By contrast, the phasing of the two interventions is qualitatively sensitive to the form of targeting. Even so, this model poses difficult technical problems, most especially as regards the sufficient conditions for a welfare-maximizing dynamic policy, something we largely addressed through numerical examples.
With regard to the other models, we provided some results, on the phasing of interventions and on the subsidies and taxes necessary to achieve decentralization. Kamien and Schwartz, 1981 ) for a maximum is therefore not fulfilled.
Despite this failure of the commonly-used sufficiency condition, we believe that the problem of section 1C is well posed and its solution is characterized by the first-order conditions and the phase diagrams. There are three reasons for our belief. First, at an intuitive level, the α and β functions may exhibit steeply diminishing returns.
In this case, it is hard to see how the solution could be characterized by anything but a conventional optimizing approach to a steady-state level of infection.
Second, consistent with this intuition, the Arrow conditions seem much stronger than are necessary. Zeiden (1984) presents weaker conditions but they are not easy to apply.
Third, and to us most convincing, we next present the results of a numerical implementation of the model using dynamic programming that seems well-behaved and The dynamic equation is the discrete version of equation (12). In this case, if nothing is 10 We used a grid of 417 points, with s ranging from 0.005 to 0.985. The density of points was not uniform and was chosen to provide increased accuracy at the limits of the range and around the steady state . We interpolated the value function for intermediate values of s using a cubic spline. We accepted that the value function had converged when the maximum proportional change in the value function at every s in an iteration was less than .000001. All calculations were done in double-precision FORTRAN. 37 done, the equilibrium is an internal one with the steady-state fraction of the population being s* = .08/.20 = 0.40 and the corresponding value of W = 6400. We found the policy rule by iterating on the value function.
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The computation seemed well-behaved and straightforward, except that there was some slight instability in the values of the controls for the last few values of s at either end of its range. This instability seemed to be associated with the interpolation because it seemed always to be pushed to the end when we added additional points. To save space, Table A We increased the four price parameters to indicate the responsiveness of the steady state value of s, s*. A ten percent increase in p I increases s* by 0.9 percent. A ten percent increase in p a decreases s* by 0.7 percent. A ten percent increase in p b decreases s* by 0.6 percent. A ten percent increase in (1+r) decreases s* by 3.2 percent. All the simulations for these comparative steady-state results as well as other similar sensitivity analysis suggest a well-behaved problem. 
